289 related articles for article (PubMed ID: 8930393)
21. Characterization of the kinase activity essential for tyrosine phosphorylation of p130Cas in fibroblasts.
Sakai R; Nakamoto T; Ozawa K; Aizawa S; Hirai H
Oncogene; 1997 Mar; 14(12):1419-26. PubMed ID: 9136985
[TBL] [Abstract][Full Text] [Related]
22. Suppression of malignant growth potentials of v-Src-transformed human gallbladder epithelial cells by adenovirus-mediated dominant negative H-Ras.
Tokumitsu Y; Nakano S; Ueno H; Niho Y
J Cell Physiol; 2000 May; 183(2):221-7. PubMed ID: 10737897
[TBL] [Abstract][Full Text] [Related]
23. Essential role of Raf in Ras transformation and deregulation of matrix metalloproteinase expression in ovarian epithelial cells.
Ulkü AS; Schäfer R; Der CJ
Mol Cancer Res; 2003 Dec; 1(14):1077-88. PubMed ID: 14707291
[TBL] [Abstract][Full Text] [Related]
24. v-Crk activates the phosphoinositide 3-kinase/AKT pathway by utilizing focal adhesion kinase and H-Ras.
Akagi T; Murata K; Shishido T; Hanafusa H
Mol Cell Biol; 2002 Oct; 22(20):7015-23. PubMed ID: 12242282
[TBL] [Abstract][Full Text] [Related]
25. A newly isolated avian sarcoma virus, ASV-1, carries the crk oncogene.
Tsuchie H; Chang CH; Yoshida M; Vogt PK
Oncogene; 1989 Nov; 4(11):1281-4. PubMed ID: 2554234
[TBL] [Abstract][Full Text] [Related]
26. Identification and characterization of a high-affinity interaction between v-Crk and tyrosine-phosphorylated paxillin in CT10-transformed fibroblasts.
Birge RB; Fajardo JE; Reichman C; Shoelson SE; Songyang Z; Cantley LC; Hanafusa H
Mol Cell Biol; 1993 Aug; 13(8):4648-56. PubMed ID: 7687742
[TBL] [Abstract][Full Text] [Related]
27. v-Crk modulation of growth factor-induced PC12 cell differentiation involves the Src homology 2 domain of v-Crk and sustained activation of the Ras/mitogen-activated protein kinase pathway.
Teng KK; Lander H; Fajardo JE; Hanafusa H; Hempstead BL; Birge RB
J Biol Chem; 1995 Sep; 270(35):20677-85. PubMed ID: 7657647
[TBL] [Abstract][Full Text] [Related]
28. Suppression of cell spreading by v-Crk requires Ras-MEK-MAP kinase signaling.
Liu Y; Hiraiwa Y; Liu E; Kurata H; Thant AA; Matsuda S; Hamaguchi M
Oncogene; 2001 Sep; 20(41):5908-12. PubMed ID: 11593397
[TBL] [Abstract][Full Text] [Related]
29. Characterization of a human MSX-2 cDNA and its fragment isolated as a transformation suppressor gene against v-Ki-ras oncogene.
Takahashi C; Akiyama N; Matsuzaki T; Takai S; Kitayama H; Noda M
Oncogene; 1996 May; 12(10):2137-46. PubMed ID: 8668339
[TBL] [Abstract][Full Text] [Related]
30. The Crk signaling pathway contributes to the bombesin-induced activation of the small GTPase Rap1 in Swiss 3T3 cells.
Posern G; Rapp UR; Feller SM
Oncogene; 2000 Dec; 19(54):6361-8. PubMed ID: 11175351
[TBL] [Abstract][Full Text] [Related]
31. Transformation by Raf and other oncogenes renders cells differentially sensitive to growth inhibition by a dominant negative c-jun mutant.
Rapp UR; Troppmair J; Beck T; Birrer MJ
Oncogene; 1994 Dec; 9(12):3493-8. PubMed ID: 7970709
[TBL] [Abstract][Full Text] [Related]
32. Biological activity of human N-ras and K-ras genes containing the Asn17 dominant negative mutation.
Kaplan JB
Oncol Res; 1994; 6(12):611-5. PubMed ID: 7787254
[TBL] [Abstract][Full Text] [Related]
33. trans-Dominant suppressor mutations of the H-ras oncogene.
Ogiso Y; Gutierrez L; Wrathall LS; Lu YY; Blair DG; Clanton DJ; Hwang YW; Shih TY
Cell Growth Differ; 1990 May; 1(5):217-24. PubMed ID: 2150753
[TBL] [Abstract][Full Text] [Related]
34. Reversion of Ras- and phosphatidylcholine-hydrolyzing phospholipase C-mediated transformation of NIH 3T3 cells by a dominant interfering mutant of protein kinase C lambda is accompanied by the loss of constitutive nuclear mitogen-activated protein kinase/extracellular signal-regulated kinase activity.
Bjorkoy G; Perander M; Overvatn A; Johansen T
J Biol Chem; 1997 Apr; 272(17):11557-65. PubMed ID: 9111071
[TBL] [Abstract][Full Text] [Related]
35. The Ras-mitogen-activated protein kinase pathway is critical for the activation of matrix metalloproteinase secretion and the invasiveness in v-crk-transformed 3Y1.
Liu E; Thant AA; Kikkawa F; Kurata H; Tanaka S; Nawa A; Mizutani S; Matsuda S; Hanafusa H; Hamaguchi M
Cancer Res; 2000 May; 60(9):2361-4. PubMed ID: 10811109
[TBL] [Abstract][Full Text] [Related]
36. v-Crk activates the phosphoinositide 3-kinase/AKT pathway in transformation.
Akagi T; Shishido T; Murata K; Hanafusa H
Proc Natl Acad Sci U S A; 2000 Jun; 97(13):7290-5. PubMed ID: 10852971
[TBL] [Abstract][Full Text] [Related]
37. The product of the cellular crk gene consists primarily of SH2 and SH3 regions.
Reichman CT; Mayer BJ; Keshav S; Hanafusa H
Cell Growth Differ; 1992 Jul; 3(7):451-60. PubMed ID: 1329926
[TBL] [Abstract][Full Text] [Related]
38. Increase in ribosomal protein S6 phosphorylation is due to v-erbB-transforming activity and not to v-erbA mitogenic activity in avian erythroblastosis virus-infected chicken embryo fibroblasts.
Diaz JJ; Gandrillon O; Hentzen D; Leguellec D; Samarut J; Madjar JJ
Oncogene Res; 1989; 4(3):163-75. PubMed ID: 2567979
[TBL] [Abstract][Full Text] [Related]
39. Possible v-Crk-induced transformation through activation of Src kinases.
Sabe H; Shoelson SE; Hanafusa H
J Biol Chem; 1995 Dec; 270(52):31219-24. PubMed ID: 8537387
[TBL] [Abstract][Full Text] [Related]
40. The v-rel oncogene encodes a cell-specific transcriptional activator of certain promoters.
Gélinas C; Temin HM
Oncogene; 1988 Oct; 3(4):349-55. PubMed ID: 2856247
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
